New evidence on atenolol in hypertension
This article has no abstract so we have provided the first paragraph of the full text.
A new systematic review by Carlberg and colleagues has revealed that atenolol, one of the most common 
-blockers, might not be appropriate as a first-line treatment for hypertension.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
